Risk and outcome of non‐Hodgkin lymphoma among classical Hodgkin lymphoma survivors

BACKGROUND Survivors of classical Hodgkin lymphoma (cHL) are at an increased risk of developing secondary non‐Hodgkin lymphomas (sNHLs). To the authors' knowledge, the outcome of patients with sNHL compared with their de novo counterparts (dnNHL) is unknown. METHODS Data from 26,826 cases of HL...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cancer Ročník 119; číslo 18; s. 3385 - 3392
Hlavní autori:	Xavier, Ana C., Armeson, Kent E., Hill, Elizabeth G., Costa, Luciano J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Hoboken, NJ Wiley-Blackwell 15.09.2013
Predmet:	Adolescent Adult Aged Aged, 80 and over Biological and medical sciences Child Child, Preschool classical Hodgkin lymphoma cohort studies Female Hematologic and hematopoietic diseases Hodgkin Disease - epidemiology Hodgkin Disease - mortality Humans Incidence Infant Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, Non-Hodgkin - epidemiology Lymphoma, Non-Hodgkin - mortality Male Medical sciences Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) non‐Hodgkin lymphoma prognosis Risk Factors second primary neoplasms SEER Program Survivors Treatment Outcome Tumors United States - epidemiology Young Adult United States Prognosis Survivor classical Hodgkin lymphoma Hodgkin disease Risk Malignant hemopathy non-Hodgkin lymphoma Malignant tumor Non Hodgkin lymphoma second primary neoplasms Cancerology Second cancer Lymphoproliferative syndrome Cohort study Risk factor cohort studies Evolution Cancer prognosis
ISSN:	0008-543X, 1097-0142, 1097-0142
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!